02Oct

Beta-blockers for heart failure with reduced mid-range and preserved ejection fraction

beta-blockers for heart failure with reduced mid-range and preserved ejection fraction

Dec 11,  · Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J, 39 (), pp. View Record in Scopus Google Scholar. Beta-blockers improve LVEF and prognosis for patients with heart failure in sinus rhythm with a reduced LVEF. The data are most robust for LVEF LVEF %.Cited by: Jan 30,  · Cleland JGF, Bunting KV, Flather MD et al. Beta-blockers in Heart Failure Collaborative Group. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. ; – doi: /eurheartj/ehxCited by: 9.

We investigated the effect of beta-blockers according to LVEF in double-blind, randomized, placebo-controlled trials. However, our data represent the vast majority of patients enrolled in double-blind RCTs of beta-blockers.

Associated Data

Eur Heart J. Eur J Heart Fail ; 12 : — Fractional polynomials were used preservde find the best transformation, 28 although a linear relationship with mortality was the best fit. John Wikstrand.

beta-blockers for heart failure with reduced mid-range and preserved ejection fraction

Email alerts Article activity alert. Figure 5.

beta-blockers for heart failure with reduced mid-range and preserved ejection fraction

Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Summary results are presented as click, or median and interquartile range IQR; displayed as 25th—75th quartiles. Kapoor et al.

beta-blockers for heart failure with reduced mid-range and preserved ejection fraction

Gov't Review Systematic Review. Influence of baseline left ventricular function hewrt the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Dirk J van Veldhuisen. As availability of follow-up LVEF is determined by survival, we chose not to perform any statistical hypothesis testing.

Aetiology and Pathophysiology

Supplementary Figure S2. Individual patient data meta-analysis. Lund LH. Patients between these two classes were previously either excluded from HF studies or were included in the other groups. Over a median of 1. Volume Lund LH. Lund et al.

Think: Beta-blockers for heart failure with reduced mid-range and preserved ejection metformin helped weight pcos SUPPLEMENTS FOR GASTRIC SLEEVE PATIENTS Cardiovascular hospitalization. All included studies had low risk of bias, as determined using the Cochrane Collaborations Risk of Bias Tool. J Am Coll Cardiol ; 61 : — Outcomes and effect measures The primary outcomes for this analysis were all-cause mortality and cardiovascular learn more here, which included additional deaths reported after the censor date for seven studies.

The increase in LVEF with beta-blockers was smaller for patients with IHD, but the benefit on mortality was similar to those with a non-ischaemic cause for heart failure. All rights reserved. A standardized data request form to obtain IPD from each trial has been published, along with search results and individual study demographics. ASCENDING AORTIC ANEURYSM REPAIR GUIDELINES Is dosulepin still available KEFLEX USED TO TREAT STD Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Is famotidine pepcid ac Heart J. Our preference in statistical analysis is always learn more here report the interaction of treatment effect across continuous variables such as LVEF, instead of relying on efficacy in subgroups.

Introduction Double-blind, randomized, beta-blockers for heart failure with reduced mid-range and preserved ejection fraction trials RCTs show that beta-blockers increase left ventricular ejection fraction LVEF and reduce morbidity and mortality for a broad range of patients reruced a reduced LVEF in sinus rhythm. Lund LH. Is gas-x bad for you 153 Effect of carvedilol on survival in severe chronic heart failure. Mortality was predominantly cardiovascular regardless of aetiology, both for patients in sinus rhythm Supplementary material reducev, Table S4 and AF Supplementary material online, Table S5and mostly attributed to sudden death or worsening heart failure.

Change in left ventricular ejection fraction LVEF from baseline in patients who survived to follow-up, with median time between measurements of 1.

Publication types

Article Navigation. Am Heart J ; : — Supplementary Figure S3 Continue reading here for additional data file. Metoprolol in dilated cardiomyopathy MDC trial study group. All data were cross-checked across different trial databases and compared with published reports. Eur Heart J. BMJ ; :i Composite of cardiovascular death. Open in a separate window. Znd between these two classes were previously either excluded from HF studies or were included in the other groups.

1 thoughts on “Beta-blockers for heart failure with reduced mid-range and preserved ejection fraction

Leave a Reply

Your email address will not be published. Required fields are marked *

1148 | 1149 | 1150 | 1151 | 1152